CXCL12 and coronary artery disorder: Based on these novel findings in this study, we can speculate that disturbance of the beneficial effects of the SDF-1α/CXCR4 pathway by the inactivated form of SDF-1α itself may lead to adverse outcomes in diabetic patients with CAD.